Skip to main content

Signal Bioscience

  • | Diagnostics
Signal Bioscience

Signal Bioscience is a Life ScienceTools company developing novel reagents to dramatically extend the capabilities of existing molecular diagnostic instruments. 


PCR (polymerase chain reaction) tests are a workhorse in Molecular Biology & Diagnostics, with over 2 Billion tests run per year globally. Our patent pending reagents make PCR instruments faster, more sensitive, and higher throughput. We plan to work with existing industry players for development partnerships & commercialization, beginning with r dPCR (digital PCR). Our reagents will allow dPCR assays to multiplex up to 100 targets/assay, enabling dPCR to perform clinical assays now conventionally run by NGS (Next Generation Sequencing.)


Our CSO was a co-founder of Rubicon Genomics (Takara) & Swift Bioscience (IDT). Our CBO was Director of Strategy for Thermo Fisher’s PCR reagent business. Our CEO ran a high throughput clinical diagnostics lab. We are planning for a Series A round in H2 2025. We are located in Ann Arbor, MI.


Address

Ann Arbor
Michigan
United States
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors